Dimensional Fund Advisors
ASTH icon

Dimensional Fund Advisors’s Astrana Health ASTH Stock Holding History

Dimensional Fund Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.5M Buy
1,368,079
+152,267
+13% +$3.61M 0.01% 1712
2025
Q4 		$30.2M Sell
1,215,812
-18,909
-2% -$502K 0.01% 1771
2025
Q3 		$35M Sell
1,234,721
-27,432
-2% -$743K 0.01% 1713
2025
Q2 		$31.4M Buy
1,262,153
+144,386
+13% +$4.07M 0.01% 1760
2025
Q1 		$34.7M Buy
1,117,767
+72,227
+7% +$2.41M 0.01% 1665
2024
Q4 		$33M Buy
1,045,540
+101,192
+11% +$4.81M 0.01% 1753
2024
Q3 		$54.7M Buy
944,348
+12,993
+1% +$638K 0.01% 1453
2024
Q2 		$37.8M Buy
931,355
+103,608
+13% +$4.11M 0.01% 1637
2024
Q1 		$34.8M Buy
827,747
+59,227
+8% +$2.31M 0.01% 1693
2023
Q4 		$29.4M Buy
768,520
+59,895
+8% +$1.99M 0.01% 1781
2023
Q3 		$21.9M Buy
708,625
+105,565
+18% +$3.64M 0.01% 1870
2023
Q2 		$19.1M Buy
603,060
+108,239
+22% +$3.71M 0.01% 1956
2023
Q1 		$18M Buy
494,821
+83,754
+20% +$2.93M 0.01% 1959
2022
Q4 		$12.2K Buy
411,067
+31,214
+8% +$1M ﹤0.01% 2110
2022
Q3 		$14.8M Sell
379,853
-17,770
-4% -$813K 0.01% 1979
2022
Q2 		$15.3M Sell
397,623
-3,617
-0.9% -$138K 0.01% 2003
2022
Q1 		$19.4M Buy
401,240
+22,761
+6% +$1.17M 0.01% 1983
2021
Q4 		$27.8M Buy
378,479
+27,416
+8% +$2.25M 0.01% 1800
2021
Q3 		$32M Buy
351,063
+105,825
+43% +$9M 0.01% 1745
2021
Q2 		$15.4M Buy
245,238
+132,285
+117% +$4.89M ﹤0.01% 2171
2021
Q1 		$3.06M Buy
112,953
+27,886
+33% +$671K ﹤0.01% 2738
2020
Q4 		$1.55M Buy
85,067
+47,294
+125% +$850K ﹤0.01% 2878
2020
Q3 		$678K Hold
37,773
– – ﹤0.01% 3007
2020
Q2 		$623K Buy
37,773
+1,664
+5% +$26.2K ﹤0.01% 3036
2020
Q1 		$467K Hold
36,109
– – ﹤0.01% 3068
2019
Q4 		$665K Sell
36,109
-1,641
-4% -$27.2K ﹤0.01% 3089
2019
Q3 		$665K Hold
37,750
– – ﹤0.01% 3096
2019
Q2 		$631K Hold
37,750
– – ﹤0.01% 3150
2019
Q1 		$692K Buy
37,750
+5,508
+17% +$106K ﹤0.01% 3109
2018
Q4 		$640K Buy
32,242
+19,561
+154% +$366K ﹤0.01% 3105
2018
Q3 		$280K Buy
+12,681
New +$267K ﹤0.01% 3265

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors's ASTH Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Astrana Health (ASTH) stake by 13% in Q1 2026, buying an estimated $3.61M and bringing the position to 1,368,079 shares worth $33.5M. The position accounts for 0.01% of the portfolio, ranked #1712.

Dimensional Fund Advisors first reported a position in ASTH in Q3 2018 and has held it in 31 quarters since. The position peaked at $54.7M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Dimensional Fund Advisors held 1,368,079 shares of Astrana Health worth $33.5M as of Q1 2026.
  • Dimensional Fund Advisors bought 152,267 Astrana Health shares in Q1 2026, an estimated $3.61M.
  • Astrana Health made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1712 holding.
  • Dimensional Fund Advisors first reported a position in Astrana Health in Q3 2018 and has held it in 31 quarters since.
  • Dimensional Fund Advisors's Astrana Health position peaked at $54.7M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.